DE69410466D1 - Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes - Google Patents

Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes

Info

Publication number
DE69410466D1
DE69410466D1 DE69410466T DE69410466T DE69410466D1 DE 69410466 D1 DE69410466 D1 DE 69410466D1 DE 69410466 T DE69410466 T DE 69410466T DE 69410466 T DE69410466 T DE 69410466T DE 69410466 D1 DE69410466 D1 DE 69410466D1
Authority
DE
Germany
Prior art keywords
image contrast
compositions
increasing
human
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69410466T
Other languages
English (en)
Other versions
DE69410466T2 (de
Inventor
Anders Ericcson
Anne Fahlvik
Anders Hemmingsson
Mats Wikstrom
Audun Oksendal
Tore Bach-Gansmo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of DE69410466D1 publication Critical patent/DE69410466D1/de
Application granted granted Critical
Publication of DE69410466T2 publication Critical patent/DE69410466T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
DE69410466T 1993-07-12 1994-07-11 Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes Expired - Lifetime DE69410466T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939314499A GB9314499D0 (en) 1993-07-12 1993-07-12 Method
PCT/GB1994/001500 WO1995002831A1 (en) 1993-07-12 1994-07-11 Methods and compositions for image contrast enhancing

Publications (2)

Publication Number Publication Date
DE69410466D1 true DE69410466D1 (de) 1998-06-25
DE69410466T2 DE69410466T2 (de) 1999-02-18

Family

ID=10738767

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69410466T Expired - Lifetime DE69410466T2 (de) 1993-07-12 1994-07-11 Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes

Country Status (14)

Country Link
US (2) US5869023A (de)
EP (1) EP0708927B1 (de)
JP (1) JPH09502426A (de)
CN (1) CN1127040A (de)
AT (1) ATE166464T1 (de)
AU (1) AU7129594A (de)
CA (1) CA2165086A1 (de)
DE (1) DE69410466T2 (de)
ES (1) ES2116600T3 (de)
GB (1) GB9314499D0 (de)
NO (1) NO960120L (de)
NZ (1) NZ268397A (de)
WO (1) WO1995002831A1 (de)
ZA (1) ZA945038B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
DE19719033C1 (de) * 1997-04-29 1999-01-28 Schering Ag Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
GB9809776D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
SE9803718D0 (sv) * 1998-05-26 1998-10-28 Klaus Potthoff Diagnostiseringsmedel
WO2000009170A1 (en) * 1998-08-10 2000-02-24 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
CZ2002343A3 (cs) * 1999-07-29 2002-08-14 Epix Medical, Inc. Cílená multimerní zobrazovací činidla s multilokální vazebnou schopností
US6804546B1 (en) * 2001-04-20 2004-10-12 Koninklijke Philips Electronics, N.V. Multiple contrast echo-planar imaging for contrast-enhanced imaging
US6723052B2 (en) * 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
NO20020780D0 (no) * 2002-02-15 2002-02-15 Amersham Health As Bildeanalyse
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
CN104656046A (zh) * 2004-05-03 2015-05-27 皇家飞利浦电子股份有限公司 磁共振成像系统和方法
CA2568952C (en) 2004-06-18 2019-05-21 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
US20060020152A1 (en) * 2004-07-22 2006-01-26 Theobald Eugene H Method for the low temperature selective oxidation of hydrogen contained in a hydrocarbon stream
NO20043746L (no) * 2004-09-07 2006-03-08 Heidi Brurok MRI-metode for a vurdere myokardisk funksjon, levedyktighet og perfusjon i ischemisk hjertesykdom
US7854705B2 (en) * 2004-12-16 2010-12-21 Olga Pawluczyk Ex vivo verification of biopsy tissue samples
JP2008541918A (ja) * 2005-06-01 2008-11-27 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Ｍｒ分子イメージングによる造影剤の分布情報の決定
EP2144554A1 (de) * 2007-04-11 2010-01-20 Oregon Health & Science University Verfahren und vorrichtung für den nicht-invasiven nachweis von kardialer fibrose
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
EP2217146A4 (de) * 2007-12-05 2015-10-14 Marval Biosciences Inc Kontrastmittel in nanogrösse und verfahren zu ihrer verwendung
WO2009152445A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
EP2332122A4 (de) 2008-10-02 2013-11-20 Univ Western Ontario System und verfahren zur bildverarbeitung
CN103518135B (zh) 2011-03-11 2016-08-17 内布拉斯加大学董事委员会 冠状动脉疾病的生物标志物
CA3006759A1 (en) 2015-11-30 2017-06-08 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
US11504546B2 (en) 2019-02-28 2022-11-22 Cowles Ventures, Llc Needle guidance device for brachytherapy and method of use
US11524176B2 (en) 2019-03-14 2022-12-13 Cowles Ventures, Llc Locator for placement of fiducial support device method
EP4192511A1 (de) 2020-08-07 2023-06-14 Fortis Therapeutics, Inc. Gegen cd46 gerichtete immunkonjugate und verfahren zur verwendung davon
US11630219B2 (en) * 2021-07-29 2023-04-18 Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C Pressure-regulating large-area windowless airflow proportional counter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
IT1246380B (it) * 1990-04-12 1994-11-18 Bracco Spa Sali insolubili di lantanidi per la visualizzazione in risonanza magnetica nucleare del tratto gastro-intestinale
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region

Also Published As

Publication number Publication date
WO1995002831A1 (en) 1995-01-26
ZA945038B (en) 1995-03-27
JPH09502426A (ja) 1997-03-11
US6045775A (en) 2000-04-04
NO960120D0 (no) 1996-01-11
EP0708927A1 (de) 1996-05-01
ES2116600T3 (es) 1998-07-16
GB9314499D0 (en) 1993-08-25
CA2165086A1 (en) 1995-01-26
EP0708927B1 (de) 1998-05-20
ATE166464T1 (de) 1998-06-15
DE69410466T2 (de) 1999-02-18
AU7129594A (en) 1995-02-13
US5869023A (en) 1999-02-09
CN1127040A (zh) 1996-07-17
NO960120L (no) 1996-03-11
NZ268397A (en) 1997-11-24

Similar Documents

Publication Publication Date Title
DE69410466D1 (de) Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes
PL323919A1 (en) Free heterocyclic methyl radicals as agent improving imaging
HK1016877A1 (en) Bioactivated diagnostic imaging contrast agents.
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
TR199902937T2 (xx) �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe eden bile�ikler ve y�ntemler.
NO991688D0 (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
DK0871440T3 (da) Behandling af negative og kognitive symptomer på skizofreni med glycinoptagelsesantagonister
ATE319825T1 (de) Verfahren und zusammensetzungen zur immunomodulation
IT1256248B (it) Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
EP0716591A4 (de) Verfahren und Präparat zum Binden von TAU und MAP2c Proteinen
DE69530570D1 (de) Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
EA199800881A1 (ru) Способ т1 - взвешенной магниторезонансной визуализации органов ретикуло-эндотелиальной системы
DE59107447D1 (de) Verfahren zur Bildverbesserung und Anordnung zur Durchführung des Verfahrens
DE69430758T2 (de) Paramagnetische diagnostische zusammensetzungen und verfahren zur verwendung
DE69419089D1 (de) Instrument zur Darstellung von Bildern des Endotheliums der Kornea
DE69924533D1 (de) Verfahren und system zur bereitstellung eines bildes des anrufers
ATE249837T1 (de) Caspase 8-inhibitoren zur immunsuppression
CA2271735A1 (en) Magnetic resonance blood pool agents
DE59508912D1 (de) Verfahren und vorrichtung zur reduzierung der bewegungsunschärfe bzw. des bildrauschens bei der abbildung von sich bewegenden gegenständen
DE69105566D1 (de) Bilderzeugungsverfahren und magnetisches Entwicklungssystem zur Durchführung des Verfahrens.
DE29617049U1 (de) Demonstrationsmodell zur 3-dimensionalen Darstellung von künstlichen Körperbestandteilen des Menschen
DD296186A5 (de) Verfahren zur allseitigen passivierung von ionensensitiven feldeffekttransistoren
EP1878796A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
ATA225394A (de) Verbesserungen am photographischen system zur erzeugung von abbildungen von makroobjekten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GE HEALTHCARE AS, OSLO, NO

8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS RECHTSANWAELTE PATENTANWAELTE, 80539 MUEN

8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 708927

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB